Veru INC. (VERU) — 8-K Filings

8-K Filings (25)

• 8-K Filing — Dec 17, 2025
• Veru Inc. Files 8-K for Material Agreement — Oct 30, 2025 Risk: medium
  Veru Inc. filed an 8-K on October 30, 2025, reporting an entry into a material definitive agreement and other events. The filing also includes financial stateme
• Veru Inc. Terminates Material Definitive Agreement — Sep 26, 2025 Risk: medium
  Veru Inc. filed an 8-K on September 26, 2025, reporting the termination of a material definitive agreement as of September 22, 2025. The filing also includes fi
• Veru Inc. Files 8-K Under 'Other Events' — Aug 27, 2025 Risk: medium
  Veru Inc. filed an 8-K on August 27, 2025, reporting an event that occurred on August 26, 2025. The filing is categorized under 'Other Events' and does not prov
• Veru Inc. Files 8-K on Financials — Aug 12, 2025 Risk: low
  Veru Inc. filed an 8-K on August 12, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The fil
• Veru Inc. Files 8-K on Security Holder Vote Matters — Jul 25, 2025 Risk: low
  Veru Inc. filed an 8-K on July 25, 2025, to report on the submission of matters to a vote of its security holders. The filing does not contain specific details
• Veru Inc. Files 8-K on Financials — May 8, 2025 Risk: low
  Veru Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The comp
• Veru Inc. Files 8-K: Director Changes & Officer Compensation — Mar 14, 2025 Risk: medium
  Veru Inc. filed an 8-K on March 14, 2025, reporting on the departure of directors, election of new directors, and compensatory arrangements for officers. The fi
• Veru Inc. Faces Potential NASDAQ Delisting — Feb 28, 2025 Risk: high
  Veru Inc. filed an 8-K on February 28, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates po
• Veru Inc. Files 8-K on Financials — Feb 13, 2025 Risk: low
  Veru Inc. filed an 8-K on February 13, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. Th
• Veru Inc. Reports Material Agreements, Asset Changes — Jan 3, 2025 Risk: medium
  Veru Inc. filed an 8-K on January 3, 2025, reporting events as of December 30, 2024. The filing indicates the entry into and termination of material definitive
• Veru Inc. Signs Material Definitive Agreement — Sep 20, 2024 Risk: medium
  Veru Inc. entered into a material definitive agreement on September 19, 2024. The company, previously known as The Female Health Co. and Wisconsin Pharmacal Com
• Veru Inc. Faces Nasdaq Delisting Warning — Aug 30, 2024 Risk: high
  Veru Inc. announced on August 29, 2024, that it received a notification from Nasdaq regarding its failure to meet the minimum bid price requirement for continue
• Veru Inc. Terminates Material Definitive Agreement — Aug 23, 2024 Risk: medium
  Veru Inc. announced on August 19, 2024, the termination of a material definitive agreement. The company, formerly known as Female Health Co. and Wisconsin Pharm
• Veru Inc. Files 8-K on Operations and Financials — Aug 8, 2024 Risk: medium
  Veru Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The fili
• Veru Inc. Appoints New Directors, Reports Executive Compensation — Aug 2, 2024 Risk: medium
  Veru Inc. announced on August 1, 2024, a change in its board of directors, with Dr. Laura L. Wingate and Dr. Richard A. U. Smith joining the board. Additionally
• Veru Inc. Files 8-K on Shareholder Vote Matters — Jul 2, 2024 Risk: low
  Veru Inc. filed an 8-K on July 2, 2024, reporting on matters submitted to a vote of security holders as of June 27, 2024. The filing details the company's corpo
• Veru Inc. Reports on Shareholder Meeting — Jun 21, 2024 Risk: low
  Veru Inc. filed an 8-K on June 21, 2024, reporting on a shareholder meeting held on June 18, 2024. The primary purpose was to vote on matters presented to secur
• Veru Inc. Appoints PricewaterhouseCoopers as New Auditor — May 22, 2024 Risk: low
  Veru Inc. announced on May 16, 2024, that it has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm. This change foll
• Veru Inc. Files 8-K on Financials — May 8, 2024 Risk: low
  Veru Inc. filed an 8-K on May 8, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The
• Veru Inc. Files 8-K: Material Definitive Agreement — Apr 26, 2024 Risk: medium
  Veru Inc. entered into a Material Definitive Agreement on April 24, 2024. The company, previously known as FEMALE HEALTH CO and WISCONSIN PHARMACAL COMPANY INC,
• Veru Inc. Raises $25M in Private Placement — Apr 25, 2024 Risk: medium
  Veru Inc. announced on April 23, 2024, that it has entered into a securities purchase agreement with institutional investors for a private placement. The compan
• VERU INC. Receives Notice of Delisting or Listing Standard Failure — Feb 28, 2024 Risk: high
  VERU INC. filed an 8-K on February 28, 2024, reporting an event that occurred on February 21, 2024. The filing indicates the company received a "Notice of Delis
• VERU INC. Discloses Non-Reliance on Past Financial Statements — Feb 15, 2024 Risk: high
  VERU INC. filed an 8-K on February 15, 2024, under Item 4.02, disclosing non-reliance on previously issued financial statements or a related audit report or com
• VERU INC. Files 8-K on Financial Results and Operations — Feb 8, 2024 Risk: low
  VERU INC. filed an 8-K on February 8, 2024, to report an event related to its financial condition and operations. This filing, under Items 2.02 and 9.01, indica

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX